Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology, 05/17/2012
Muether PS et al. – Latency between indication to treat and treatment is responsible for irreversible visual acuity deterioration. A successful PRN treatment regimen for neovascular age–related macular degeneration requires immediate access to therapy after indication.